Welcome & Introduction
Decoding Treatment Options for EGFRm NSCLC
Osimertinib as Adjuvant Therapy in patients with resected EGFRm Stage IB IIIA NSCLC-Updated Results from ADAURA
Welcome & Introduction
How I Treat ES-SCLC with Durvalamb-Real world experience
Optimizing Treatment Decisions in Unresectable Stage-III NSCLC-A Case Study